Fonseca A, Sereno J, Almeida S, Ferreira H, Hrynchak I, Falcao A
Eur J Nucl Med Mol Imaging. 2025; .
PMID: 39909885
DOI: 10.1007/s00259-025-07116-2.
Halperin R, Tirosh A
Fam Cancer. 2025; 24(1):15.
PMID: 39826015
PMC: 11742904.
DOI: 10.1007/s10689-025-00440-4.
Bahou K, Achour Y, Ilahiane M, Sekkat H, Bakali Y, Mhamdi Alaoui M
Rare Tumors. 2025; 17():20363613241313409.
PMID: 39790868
PMC: 11713962.
DOI: 10.1177/20363613241313409.
Tsoli M, Panagaki M, Tasouli E, Kolomodi D, Kaltsas G
Curr Oncol Rep. 2025; 27(1):59-67.
PMID: 39757325
DOI: 10.1007/s11912-024-01631-5.
Marasco M, Romano E, Arrivi G, Prosperi D, Rinzivillo M, Caruso D
Cancers (Basel). 2024; 16(22).
PMID: 39594786
PMC: 11592972.
DOI: 10.3390/cancers16223831.
Radiomics in advanced gastroenteropancreatic neuroendocrine neoplasms: Identifying responders to somatostatin analogs.
Polici M, Caruso D, Masci B, Marasco M, Valanzuolo D, DellUnto E
J Neuroendocrinol. 2024; 37(1):e13472.
PMID: 39564809
PMC: 11750307.
DOI: 10.1111/jne.13472.
Synergizing traditional CT imaging with radiomics: a novel model for preoperative diagnosis of gastric neuroendocrine and mixed adenoneuroendocrine carcinoma.
He X, Yang S, Ren J, Wang N, Li M, You Y
Front Oncol. 2024; 14:1480466.
PMID: 39507752
PMC: 11538776.
DOI: 10.3389/fonc.2024.1480466.
Neuroendocrine tumours and pregnancy: Real-world data from an European Neuroendocrine Tumour Centre of Excellence.
Ratnayake G, Shekhda K, Glover T, Al-Obudi Y, Hayes A, Armonis P
J Neuroendocrinol. 2024; 37(1):e13465.
PMID: 39503166
PMC: 11750320.
DOI: 10.1111/jne.13465.
Liver metastases in high-grade neuroendocrine neoplasms: A comparative study of hepatic tumor volume and biochemical findings in NET G3 versus NEC.
Melhorn P, Raderer M, Mazal P, Berchtold L, Beer L, Kiesewetter B
J Neuroendocrinol. 2024; 36(12):e13454.
PMID: 39402903
PMC: 11646661.
DOI: 10.1111/jne.13454.
Radioligand therapy in the therapeutic strategy for patients with gastro-entero-pancreatic neuroendocrine tumors: a consensus statement from the Italian Association for Neuroendocrine Tumors (Itanet), Italian Association of Nuclear Medicine (AIMN),....
Panzuto F, Albertelli M, De Rimini M, Rizzo F, Grana C, Cives M
J Endocrinol Invest. 2024; 48(1):23-36.
PMID: 39395114
PMC: 11729074.
DOI: 10.1007/s40618-024-02448-6.
ESR Essentials: role of PET/CT in neuroendocrine tumors-practice recommendations by the European Society for Hybrid, Molecular and Translational Imaging.
Ebner R, Sheikh G, Brendel M, Ricke J, Cyran C
Eur Radiol. 2024; .
PMID: 39387873
DOI: 10.1007/s00330-024-11095-7.
A clinician's perspective on the new organ mesentery and non-vascular mesenteropathies.
Ahmed M
Front Physiol. 2024; 15:1336908.
PMID: 39296517
PMC: 11408482.
DOI: 10.3389/fphys.2024.1336908.
Primary coexisting adenocarcinoma of the colon and neuroendocrine tumor of the duodenum: A case report and review of the literature.
Fei S, Wu W, Zhang H, Liu S, Li D, Jin B
World J Gastrointest Surg. 2024; 16(8):2724-2734.
PMID: 39220064
PMC: 11362920.
DOI: 10.4240/wjgs.v16.i8.2724.
A novel model for predicting postoperative liver metastasis in R0 resected pancreatic neuroendocrine tumors: integrating computational pathology and deep learning-radiomics.
Ma M, Gu W, Liang Y, Han X, Zhang M, Xu M
J Transl Med. 2024; 22(1):768.
PMID: 39143624
PMC: 11323380.
DOI: 10.1186/s12967-024-05449-4.
Diagnostic Challenges in Difficult-to-Localize Insulinomas: A Case Report and Review of Literature.
Grubor N, Grubor N, Micev M
Diagnostics (Basel). 2024; 14(15).
PMID: 39125476
PMC: 11311322.
DOI: 10.3390/diagnostics14151600.
Advancements in Neuroendocrine Neoplasms: Imaging and Future Frontiers.
Asmundo L, Rizzetto F, Blake M, Anderson M, Mojtahed A, Bradley W
J Clin Med. 2024; 13(11).
PMID: 38892992
PMC: 11172657.
DOI: 10.3390/jcm13113281.
Portuguese Pancreatic Club Perspectives on Pancreatic Neuroendocrine Neoplasms: Diagnosis and Staging, Associated Genetic Syndromes and Particularities of Their Clinical Approach.
Ferreira-Silva J, Meireles S, Falconi M, Fernandes A, Vilas-Boas F, Bispo M
GE Port J Gastroenterol. 2024; 31(3):153-164.
PMID: 38836119
PMC: 11149993.
DOI: 10.1159/000534641.
[Imaging of pancreatic neuroendocrine tumors].
Berger F, Ingenerf M, Auernhammer C, Cyran C, Ebner R, Zacherl M
Radiologie (Heidelb). 2024; 64(7):559-567.
PMID: 38789854
DOI: 10.1007/s00117-024-01316-x.
[Clinical significance of neuroendocrine tumors : Incidence, symptoms, diagnosis, stage, and prognostic factors and their influence on disease management].
Hartrampf P, Serfling S, Higuchi T, Bojunga J, Weich A, Werner R
Radiologie (Heidelb). 2024; 64(7):536-545.
PMID: 38777918
DOI: 10.1007/s00117-024-01315-y.
Validation of the standardization framework SSTR-RADS 1.0 for neuroendocrine tumors using the novel SSTR‑targeting peptide [F]SiTATE.
Ebner R, Lohse A, Fabritius M, Rubenthaler J, Wangler C, Wangler B
Eur Radiol. 2024; 34(11):7222-7232.
PMID: 38769164
PMC: 11519286.
DOI: 10.1007/s00330-024-10788-3.
